AT383736B - Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen - Google Patents

Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen

Info

Publication number
AT383736B
AT383736B AT0287185A AT287185A AT383736B AT 383736 B AT383736 B AT 383736B AT 0287185 A AT0287185 A AT 0287185A AT 287185 A AT287185 A AT 287185A AT 383736 B AT383736 B AT 383736B
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
producing water
soluble pharmaceutical
soluble
producing
Prior art date
Application number
AT0287185A
Other languages
English (en)
Other versions
ATA287185A (de
Inventor
Stefania Meola
Original Assignee
Schering Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Spa filed Critical Schering Spa
Publication of ATA287185A publication Critical patent/ATA287185A/de
Application granted granted Critical
Publication of AT383736B publication Critical patent/AT383736B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505Phosphonic acids containing oxirane groups; esters thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0287185A 1984-10-05 1985-10-03 Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen AT383736B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4792/84A CH660306A5 (de) 1984-10-05 1984-10-05 Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.

Publications (2)

Publication Number Publication Date
ATA287185A ATA287185A (de) 1987-01-15
AT383736B true AT383736B (de) 1987-08-10

Family

ID=4282621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0287185A AT383736B (de) 1984-10-05 1985-10-03 Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen

Country Status (11)

Country Link
JP (1) JPS62223121A (de)
KR (1) KR860003012A (de)
AT (1) AT383736B (de)
BE (1) BE903369A (de)
CH (1) CH660306A5 (de)
DE (1) DE3535356A1 (de)
ES (1) ES8609351A1 (de)
FR (1) FR2571255B1 (de)
GB (1) GB2165152B (de)
IT (1) IT1201479B (de)
NL (1) NL8502712A (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311956A (en) * 1969-10-02 1973-03-28 Merck & Co Inc Method of potentiating the activity of phosphonomycin antibiotics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH310498A (de) * 1951-11-14 1955-10-31 Waldhof Zellstoff Fab Verfahren zur Stabilisierung von Alkalisalzen von Adenosinpolyphosphorsäuren.
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
US3639590A (en) * 1967-07-25 1972-02-01 Merck & Co Inc Antibacterial composition containing (-) (cis-1 2-epoxypropyl) phosphoric acid
IT1161974B (it) * 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
DE2813814A1 (de) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Hochwirksame, enteral resorbierbare pharmazeutische praeparate
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1097578B (it) * 1978-07-31 1985-08-31 Italchemi Spa Metodo per la preparazione di sali dell'acido (-)
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311956A (en) * 1969-10-02 1973-03-28 Merck & Co Inc Method of potentiating the activity of phosphonomycin antibiotics

Also Published As

Publication number Publication date
GB2165152A (en) 1986-04-09
CH660306A5 (de) 1987-04-15
GB8524550D0 (en) 1985-11-06
JPS62223121A (ja) 1987-10-01
DE3535356A1 (de) 1986-04-24
IT8522367A0 (it) 1985-10-04
BE903369A (nl) 1986-02-03
GB2165152B (en) 1988-03-16
NL8502712A (nl) 1986-05-01
ES547625A0 (es) 1986-09-01
IT1201479B (it) 1989-02-02
FR2571255B1 (fr) 1988-09-16
FR2571255A1 (fr) 1986-04-11
ATA287185A (de) 1987-01-15
KR860003012A (ko) 1986-05-19
ES8609351A1 (es) 1986-09-01

Similar Documents

Publication Publication Date Title
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
PT80641A (de) Verfahren zur herstellung von dialkoxypyridinen
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DE3761762D1 (de) Verfahren zur herstellung von fluoraliphatischen aetherhaltigen carbonylfluoridzusammensetzungen.
DE3784123D1 (de) Verfahren zur herstellung keramischer verbundwerkstoffe.
AT381025B (de) Verfahren zur herstellung von topischen pharmazeutischen zubereitungen
ATA337285A (de) Verfahren zur herstellung von isosilybinfreiem silibinin
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
DE3575128D1 (de) Verfahren zur herstellung von 4-acetoxy-3-hydroxyethylazetizin-2-on derivaten.
DE3780527D1 (de) Verfahren zur herstellung von 5'-guanyl-saeure.
ATA221181A (de) Verfahren zur herstellung von einer pharmazeutischen zusammensetzung
DE3875280D1 (de) Verfahren zur herstellung von 9(11)-dehydro-steroidderivaten.
DE3578417D1 (de) Verfahren zur herstellung von alpha-arylalkansaeuren.
AT383735B (de) Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
DE3586741D1 (de) Verfahren zur herstellung von 5'-guanylsaeure.
AT387716B (de) Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen
AT383736B (de) Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
ATA178085A (de) Verfahren zur herstellung von 1-thiosubstituierten n-methyl-2-nitroaethenaminen
DE3576820D1 (de) Verfahren zur herstellung von cycloalkylaminophenolderivaten.
AT383272B (de) Verfahren zur herstellung von pharmazeutischen tabletten
ATA282984A (de) Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung
ATA252985A (de) Verfahren zur herstellung von
DE3775094D1 (de) Verfahren zur herstellung von 4'-hydroxybiphenyl-4-carbonsaeure.
DE3765505D1 (de) Verfahren zur herstellung von vinylphosphonsaeuredichlorid.
ATA206087A (de) Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee